Understanding Left Ventricle End-Diastolic Dimension (LVEDD): Normal vs Optimal Ranges

?What is Left Ventricle End-Diastolic Dimension (LVEDD)?

Left ventricle end-diastolic dimension (LVEDD) measures the diameter of the left ventricle at the end of the relaxation phase, typically assessed via echocardiography. This measurement reflects the chamber's resting size and is a key indicator of cardiac structure and function. Elevated LVEDD may suggest ventricular dilation, while reduced values are less commonly clinically significant.

!Why It Matters

LVEDD is an important marker of left ventricular size and can help identify cardiac remodelling or dysfunction. Enlarged LVEDD may be associated with heart failure, hypertension, or valve disease, and may suggest increased risk of future cardiac complications. Serial measurements help track disease progression and treatment response.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Shortness of breath, especially during exertion
• Fatigue and reduced exercise tolerance
• Swelling in legs, ankles, or abdomen
• Irregular heartbeat or palpitations
• Chest discomfort or pressure

How to Improve Your Levels

• 1Manage blood pressure through lifestyle modification and medications as prescribed
• 2Reduce sodium intake to lower fluid retention and cardiac workload
• 3Engage in regular, moderate aerobic exercise as tolerated and approved by your cardiologist
• 4Maintain a heart-healthy diet rich in vegetables, whole grains, and lean proteins
• 5Limit alcohol consumption and avoid smoking
• 6Take cardiac medications (ACE inhibitors, beta-blockers) as directed to reduce remodelling

When to Test

LVEDD is typically measured during a baseline echocardiogram for patients with symptoms of heart disease, a history of hypertension, known valve disease, or family history of cardiomyopathy. Serial measurements are often repeated annually or when there are changes in clinical status.

Related Biomarkers